What is TB-500 (Thymosin Beta-4)?
Thymosin Beta-4 is a naturally occurring peptide found in high concentrations in blood platelets and wound fluid. TB-500 is a synthetic version of the active domain of this protein. It is widely investigated for its ability to promote actin cell migration, angiogenesis (new blood vessel growth), and tissue repair.
Unlike BPC-157, which acts locally, TB-500 has a systemic distribution, meaning it can migrate to distant areas of injury to coordinate recovery mechanisms. This makes it an ideal model for systemic tissue repair, muscle tears, and ligament regeneration research.
Standard Reconstitution and Syringe Calculations
TB-500 is typically sold in 5mg or 10mg lyophilized vials. To mix a 5mg vial:
1. Slowly add 2.0 ml of bacteriostatic water to the vial, aiming at the glass wall.
2. Allow the vial to dissolve completely without shaking.
3. This creates a concentration of 2.5mg (2500mcg) per ml of solution.
On a U-100 syringe (where 100 units = 1.0ml), a target research dose of 2.5mg corresponds to drawing the syringe to the full 1.0ml line (100 units). For smaller research doses, such as 500mcg, the syringe is drawn to the 20-unit mark.
Combining TB-500 with BPC-157
Many researchers study the combination of TB-500 and BPC-157 due to their complementary mechanisms. BPC-157 upregulates growth hormone receptors and increases local vascular endothelial growth factor (VEGF), while TB-500 facilitates actual cell migration and structural remodeling.
Using a pre-mixed, co-lyophilized stack (such as the Wolverine Blend) ensures a precise 1:1 ratio in the same vial, simplifying reconstitution and ensuring consistent dosing ratios in cellular repair studies.